RHK 📈 RHÖN-KLINIKUM - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0007042301
RHK: Hospital, Healthcare, Medical, Rehabilitation, Acute Care Services
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany. Web URL: https://www.rhoen-klinikum-ag.com
Additional Sources for RHK Stock
RHK Stock Overview
| Market Cap in USD | 963m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception |
RHK Stock Ratings
| Growth 5y | -33.7% |
| Fundamental | 32.0% |
| Dividend | 10.8% |
| Rel. Strength Industry | 1456 |
| Analysts | - |
| Fair Price Momentum | 13.95 EUR |
| Fair Price DCF | 12.60 EUR |
RHK Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 77.7% |
RHK Growth Ratios
| Growth Correlation 3m | 60.7% |
| Growth Correlation 12m | 71.9% |
| Growth Correlation 5y | -91.1% |
| CAGR 5y | -4.53% |
| CAGR/Mean DD 5y | -0.21 |
| Sharpe Ratio 12m | 0.93 |
| Alpha | 29.69 |
| Beta | 0.05 |
| Volatility | 27.37% |
| Current Volume | 2.1k |
| Average Volume 20d | 3k |
What is the price of RHK stocks?
As of December 21, 2024, the stock is trading at EUR 13.80 with a total of 2,050 shares traded.
Over the past week, the price has changed by +2.96%, over one month by +10.32%, over three months by +11.20% and over the past year by +36.27%.
As of December 21, 2024, the stock is trading at EUR 13.80 with a total of 2,050 shares traded.
Over the past week, the price has changed by +2.96%, over one month by +10.32%, over three months by +11.20% and over the past year by +36.27%.
Is RHÖN-KLINIKUM a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, RHÖN-KLINIKUM is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.03 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RHK as of December 2024 is 13.95. This means that RHK is currently overvalued and has a potential downside of 1.09%.
Neither. Based on ValueRay Fundamental Analyses, RHÖN-KLINIKUM is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.03 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RHK as of December 2024 is 13.95. This means that RHK is currently overvalued and has a potential downside of 1.09%.
Is RHK a buy, sell or hold?
RHÖN-KLINIKUM has no consensus analysts rating.
RHÖN-KLINIKUM has no consensus analysts rating.
What are the forecast for RHK stock price target?
According to ValueRays Forecast Model, RHK RHÖN-KLINIKUM will be worth about 15.1 in December 2025. The stock is currently trading at 13.80. This means that the stock has a potential upside of +9.2%.
According to ValueRays Forecast Model, RHK RHÖN-KLINIKUM will be worth about 15.1 in December 2025. The stock is currently trading at 13.80. This means that the stock has a potential upside of +9.2%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 14 | 1.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 15.1 | 9.2% |